FDAnews Device Daily Bulletin

Myriad Genetics Launches BRCA Testing Ad Campaign in Northeast

A A

This month Myriad Genetics began marketing BRACAnalysis, its proprietary test for breast cancer genes BRCA1 and BRCA2, directly to consumers (DTC) in several Northeastern states. The campaign stirred controversy even before its launch; some health care providers believe it will lead to inappropriate testing or worse.
Genetics & Public Policy Center